racing

Looks like a good time to get in to me.

Check the SLA presentation.

Equine Gastric Ulcer Syndrome. Solagran and BioProspect have been approached
recently by thoroughbred owners from the Middle East interested in the potential of
Bioeffectives A and I to be used in combination as a treatment for EGUS, a condition
endemic in the racing industry worldwide.
If adopted, this could translate into a demand of 7g of Bioeffective A per day per animal
(equivalent to more than two packs of Bioeffective A 320 every three days)

I don't own BPO ATM